tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
Want to see RPRX full AI Analyst Report?

Royalty Pharma (RPRX) Revenue

1,302 Followers

Royalty Pharma Revenue

Royalty Pharma had a revenue of 630.58M in the quarter ending Mar 31, 2026, with 1.38%. This bring the company's revenue in the last twelve months to 2.44B, Decreased 2.62%. In the fiscal year ending Dec 31, 2025, Royalty Pharma had annual revenue of 2.38B with 5.06% growth.
Revenue (ttm)
2.44B
Revenue Growth
7.79%
P/S Ratio
12.61
Revenue/Employee
$31,709,240
Employees
75
Market Cap
$29.99B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
2.38B114.62M+5.06%
Dec 31, 2024
2.26B-90.98M-3.86%
Dec 31, 2023
2.35B117.34M+5.24%
Dec 31, 2022
2.24B-52.25M-2.28%
Dec 31, 2021
2.29B167.11M+7.87%
Dec 31, 2020
2.12B308.10M+16.98%
Dec 31, 2019
1.81B19.36M+1.08%
Dec 31, 2018
1.79B196.96M+12.33%
Dec 31, 2017
1.60B